SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-22-005617
Filing Date
2022-04-12
Accepted
2022-04-12 16:28:38
Documents
5
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 PRE 14A crsp-pre_14a-2022.htm PRE 14A 2891354
2 GRAPHIC img187354634_0.jpg GRAPHIC 19505
3 GRAPHIC img187354634_1.jpg GRAPHIC 25755
4 GRAPHIC img187354634_2.jpg GRAPHIC 742846
5 GRAPHIC img187354634_3.jpg GRAPHIC 383597
  Complete submission text file 0000950170-22-005617.txt   4506339
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37923 | Film No.: 22822570
SIC: 2836 Biological Products, (No Diagnostic Substances)